These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8153666)

  • 1. The chemotherapy of high-grade astrocytomas.
    Lesser GJ; Grossman S
    Semin Oncol; 1994 Apr; 21(2):220-35. PubMed ID: 8153666
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience.
    Fine HA; Antman KH
    Bone Marrow Transplant; 1992 Oct; 10(4):315-21. PubMed ID: 1330152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for high-grade gliomas.
    Galanis E; Buckner J
    Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 5. Regression of grade III astrocytoma during the treatment of CML with imatinib mesylate.
    Jayawardena S; Sooriabalan D; Indulkar S; Kim HH; Matin A; Maini A
    Am J Ther; 2006; 13(5):458-9. PubMed ID: 16988542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis.
    Huncharek M; Muscat J; Geschwind JF
    Anticancer Res; 1998; 18(6B):4693-7. PubMed ID: 9891542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children.
    Sawamura Y; Kamoshima Y; Kato T; Tajima T; Tsubaki J
    Jpn J Clin Oncol; 2009 May; 39(5):277-83. PubMed ID: 19224939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of high-dose chemotherapy with hemopoietic stem-cell support in the treatment of adult patients with high-grade glioma].
    Linassier C; Destrieux C; Benboubker L; Alcaraz L; Bergemer-Fouquet AM; Jan M; Calais G; Colombat P
    Bull Cancer; 2001 Sep; 88(9):871-6. PubMed ID: 11604360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy in brain tumors].
    van den Bent MJ; Schellens JH; Sillevis Smitt PA; Vecht CJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(13):702-6. PubMed ID: 8668248
    [No Abstract]   [Full Text] [Related]  

  • 10. Intratumoral chemotherapy.
    Walter KA; Tamargo RJ; Olivi A; Burger PC; Brem H
    Neurosurgery; 1995 Dec; 37(6):1128-45. PubMed ID: 8584154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors.
    Vaughan WP
    Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted delivery in primary and metastatic brain tumors: summary report of the seventh annual meeting of the Blood-Brain Barrier Disruption Consortium.
    Doolittle ND; Abrey LE; Ferrari N; Hall WA; Laws ER; McLendon RE; Muldoon LL; Peereboom D; Peterson DR; Reynolds CP; Senter P; Neuwelt EA
    Clin Cancer Res; 2002 Jun; 8(6):1702-9. PubMed ID: 12060607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological aspects of brain tumors: therapeutic implications].
    Knerich R; Butti G; Robustelli della Cuna G; Gaetani P; Ubezzi G; Paoletti P
    G Ital Chemioter; 1985; 32(1):77-81. PubMed ID: 3007256
    [No Abstract]   [Full Text] [Related]  

  • 14. [Various methodologic principles in the chemotherapy of malignant brain tumors].
    Romodanov AP; Sosnov IuD
    Vopr Neirokhir; 1973; 37(5):14-8. PubMed ID: 4591507
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy for low-grade gliomas.
    Mason WP
    Forum (Genova); 2000; 10(2):95-104. PubMed ID: 10875972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of chemotherapy for malignant brain tumors].
    Takeshima H; Kuratsu J
    No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resent advances in chemotherapy for malignant brain tumors].
    Shibui S
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):442-7. PubMed ID: 15853207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in chemotherapy for brain tumors.
    Conrad CA; Milosavljevic VP; Yung WK
    Neurol Clin; 1995 Nov; 13(4):795-812. PubMed ID: 8583997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature.
    Seifert G; Reindl T; Lobitz S; Seeger K; Henze G
    Haematologica; 2006 Jun; 91(6 Suppl):ECR23. PubMed ID: 16785126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
    Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.